LumiraDx Limited

-0.08 (-5.52%)
6:46:37 PM EDT: $1.42 +0.05 (+3.66%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Market Cap (Intraday)456.46M
Current PEN/A
Forward PE N/A
2yr Forward PE N/A
See more stats
Estimates Current Quarter
Revenue$42.24 Million
Adjusted EPS-$0.19
See more estimates
10-Day MA$1.35
50-Day MA$1.08
200-Day MA$3.12
See more pivots

LumiraDx Limited Stock, NASDAQ:LMDX

3 More London Riverside, London, Argyll and Bute SE1 2AQ
United Kingdom
Number of Employees: 1513


LumiraDX Ltd. is a next-generation point of care diagnostics company, which engages in the provision of an innovative diagnostic platform that supports a menu of tests with lab-comparable performance at the point of care. The firm's diagnostic testing solutions are being deployed by governments and healthcare institutions across laboratories, urgent care, physician offices, pharmacies, schools, and workplaces to screen, diagnose, and monitor wellness as well as disease. It also has a comprehensive portfolio of COVID-19 testing solutions from the lab to point of need. The company was founded by Ronald Zwanziger, David Scott, and Jerry McAleer in 2014 and is headquartered in London, the United Kingdom.